Ginkgo Bioworks Holdings DNA
NYSE DNA
$7.84 +0.78 (+11.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026)

Ginkgo Bioworks Holdings' (DNA) quarterly Change in Acquisitions & Divestments came in at $58.0 million in Q2 2026, down 10.73% on a YoY basis from $65.0 million in Q2 2025, and down 46.39% quarter-over-quarter from $108.2 million in Q1 2026.

Analysis

Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $58.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Acquisitions & Divestments fell 10.73% year-over-year to $58.0 million; the trailing twelve-month figure through Jun 2026 stood at $260.7 million (up 275.22% YoY), and the FY2025 full-year result was $159.5 million, up 3429.17% from the prior year.
  • Change in Acquisitions & Divestments slipped to $58.0 million in Q2 2026 per DNA's latest filing, from $108.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $108.2 million in Q1 2026 and bottomed at -$30000.0 in Q2 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $36.7 million across 4 years, with a median of $8.6 million in 2025.
  • The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments tumbled 129.13% in 2022, then jumped 15020.42% in 2025.
  • Over 4 years, Change in Acquisitions & Divestments stood at -$30000.0 in 2022, then soared by 1993.33% to $568000.0 in 2024, then surged by 15020.42% to $85.9 million in 2025, then tumbled by 32.48% to $58.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $58.0 million, $108.2 million, and $85.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.99 Mn
Mar 31, 2026 108.18 Mn
Dec 31, 2025 85.88 Mn
Sep 30, 2025 8.64 Mn
Jun 30, 2025 64.96 Mn
Dec 31, 2024 568,000.00
Sep 30, 2024 3.95 Mn
Jun 30, 2022 -30,000.00
Mar 31, 2022 58,000.00
Jun 30, 2021 103,000.00
Mar 31, 2021 99,000.00